JESSICA HUFFSTUTTER, MD

New patient office or other outpatient visit, 45-59 minutes

Administration of chemotherapy into vein, 1 hour or less

Dxa bone density measurement of hip, pelvis, spine

Established patient office or other outpatient visit, 30-39 minutes

Aspiration and/or injection of fluid from large joint

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Established patient office or other outpatient visit, 20-29 minutes

Administration of chemotherapy into vein, each additional hour

Injection of trigger points, 1-2 muscles

Injection, infliximab, excludes biosimilar, 10 mg

X-ray of upper spine, 4-5 views

X-ray of knee, 4 or more views

X-ray of lower and sacral spine, 2-3 views

X-ray of chest, 2 views

Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

X-ray of foot, minimum of 3 views

X-ray of pelvis, 1-2 views

X-ray of hand, 2 views

Injection, golimumab, 1 mg, for intravenous use

Injection of drug or substance under skin or into muscle

Vitamin d-3 level

Injection, denosumab, 1 mg

Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

Blood test, comprehensive group of blood chemicals

Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

Creatine kinase (cardiac enzyme) level, total

Uric acid level, blood

Measurement c-reactive protein for detection of infection or inflammation

Red blood cell sedimentation rate, to detect inflammation, automated

Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

Automated urinalysis test

Insertion of needle into vein for collection of blood sample

Injection, triamcinolone acetonide, not otherwise specified, 10 mg